Abstract
AbstractAll optical isomers of an optically active medicinal substance require experimental and clinical testing. In this process, as a rule, in silico methods are used in the first stage of screening for pharmacologically active substances. These methods predict the activity of chiral structures.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have